Top Markets
Coin of the day
Pascal Biosciences Inc. Pascal Biosciences Inc.

Pascal Biosciences Inc.

PSCBF
Rang in Aktien #37975
Pascal Biosciences Inc. is an innovative biopharmaceutical firm dedicated to... Pascal Biosciences Inc. is an innovative biopharmaceutical firm dedicated to discovering and advancing therapeutic solutions for oncology and bolstering immune system function. The company's robust pipeline includes several key candidates: PAS-403, a potent mitosis inhibitor designed to impede cancerous cell division, specifically targeting glioblastoma and secondary brain tumors; and PAS-393, an immunomodulatory cannabinoid developed to enhance the immune system's recognition of tumor cells when utilized alongside checkpoint inhibitor therapy. Furthermore, Pascal is progressing a specialized antibody therapy aimed at B-cells, intended for conditions like acute lymphoblastic leukemia and various B-cell lymphomas. The company is also investigating cannabinoid-derived products as potential treatments for COVID-19. To support its research, Pascal Biosciences maintains an exclusive licensing agreement with the University of Washington for a cannabinoid-based therapeutic against glioblastoma multiforme and brain metastases. It also benefits from a collaborative research partnership with SoRSE Technology Corporation, focused on advancing PAS-393 toward clinical trials. Founded in 2011, the company operates from its headquarters in Seattle, Washington.
Aktienkurs
$0.1
Zuletzt synchronisiert: 2024-06-18
Marktkapitalisierung
$1.31M
Veränderung (1 Tag)
0.00%
Veränderung (1 Jahr)
0.00%
Land
US
Handel Pascal Biosciences Inc. (PSCBF)

Kategorie

EPS für Pascal Biosciences Inc. (PSCBF)
EPS zum February 2024 TTM: $-0.01
Laut den aktuellen Finanzberichten und dem Aktienkurs von Pascal Biosciences Inc. beträgt das aktuelle EPS des Unternehmens (TTM) $-0.01. Am Ende des Jahres 2022 betrug das EPS $-0.03 ein Rückgang im Vergleich zu dem EPS von 2021, das $-0.07 betrug.
EPS-Verlauf von Pascal Biosciences Inc. von 2019 bis 2026
EPS am Ende jedes Jahres
Jahr EPS ändert
2026 (TTM) $-0.01 -5.00%
2023 $-0.01 -54.55%
2022 $-0.03 -59.08%
2021 $-0.07 -21.22%
2020 $-0.09 -64.47%
2019 $-0.24 0.00%
EPS für ähnliche Unternehmen oder Wettbewerber
Unternehmen EPS EPS-Differenz Land
$17.32 -182,415.79%
US
$27.74 -292,100.00%
NL
- -
CH
- -
KR
$13.70 -144,311.58%
BE